Sökning: WFRF:(Marconi Alessandro) > Increased use of cr...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05431naa a2200661 4500 | |
001 | oai:DiVA.org:umu-159078 | |
003 | SwePub | |
008 | 190520s2019 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:5ee01ea4-4138-4b01-9013-c9dd7f4a499d | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1590782 URI |
024 | 7 | a https://doi.org/10.1080/21681805.2019.15889192 DOI |
024 | 7 | a https://lup.lub.lu.se/record/5ee01ea4-4138-4b01-9013-c9dd7f4a499d2 URI |
040 | a (SwePub)umud (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Dabestani, Saeedu Lund University,Lunds universitet,Urologi,Forskargrupper vid Lunds universitet,Urology,Lund University Research Groups,Skåne University Hospital4 aut0 (Swepub:lu)med-sdd |
245 | 1 0 | a Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized RCC :b results from a European multicenter database (RECUR) |
264 | c 2019-03-25 | |
264 | 1 | b Taylor & Francis Group,c 2019 |
338 | a print2 rdacarrier | |
520 | a Objective: Modality and frequency of image-based renal cell carcinoma (R.C.C.) follow-up strategies are based on risk of recurrence. Using the R.E.C.U.R.-database, frequency of imaging was studied in regard to prognostic risk groups. Furthermore, it was investigated whether imaging modality utilized in contemporary follow-up were associated with outcome after detection of recurrence. Moreover, outcome was compared based on whether the assessment of potential curability was a pre-defined set of criteria's (per-protocol) or stated by the investigator. Materials and methods: Consecutive non-metastatic R.C.C. patients (n = 1,612) treated with curative intent at 12 institutes across eight European countries between 2006 and 2011 were included. Leibovich or U.I.S.S. risk group, recurrence characteristics, imaging modality, frequency and survival were recorded. Primary endpoints were overall survival (O.S.) after detection of recurrence and frequency of features associated with favourable outcome (non-symptomatic recurrences and detection within the follow-up-programme). Results: Recurrence occurred in 336 patients. Within low, intermediate and high risk for recurrence groups, the frequency of follow-up imaging was highest in the early phase of follow-up and decreased significantly over time (p < 0.001). However, neither the image modality for detection nor >= 50% cross-sectional imaging during follow-up were associated with improved O.S. after recurrence. Differences between per protocol and investigator based assessment of curability did not translate into differences in O.S. Conclusions: As expected, the frequency of imaging was highest during early follow-up. Cross-sectional imaging use for detection of recurrences following surgery for localized R.C.C. did not improve O.S. post-recurrence. Prospective studies are needed to determine the value of imaging in follow-up. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng |
653 | a Renal cell carcinoma | |
653 | a follow-up | |
653 | a imaging | |
653 | a overall survival | |
653 | a follow-up | |
653 | a imaging | |
653 | a overall survival | |
653 | a Renal cell carcinoma | |
700 | 1 | a Beisland, Christianu Haukeland University Hospital,University of Bergen4 aut |
700 | 1 | a Stewart, Grant D.u University of Cambridge4 aut |
700 | 1 | a Bensalah, Karimu University of Rennes I4 aut |
700 | 1 | a Gudmundsson, Eirikuru National University Hospital of Iceland4 aut |
700 | 1 | a Lam, Thomas B.u University of Aberdeen4 aut |
700 | 1 | a Gietzmann, Williamu University of Aberdeen4 aut |
700 | 1 | a Zakikhani, Paimaunu Aberdeen Royal Infirmary4 aut |
700 | 1 | a Marconi, Lorenzou University Hospital of Coimbra4 aut |
700 | 1 | a Fernandéz-Pello, Sergiou University Hospital Cabueñes4 aut |
700 | 1 | a Monagas, Serenellau San Agustin University Hospital4 aut |
700 | 1 | a Williams, Samuel P.u University of Edinburgh4 aut |
700 | 1 | a Powles, Thomasu Queen Mary University4 aut |
700 | 1 | a Van Werkhovenn, Eriku Netherlands Cancer Institute4 aut |
700 | 1 | a Meijer, Richardu University Medical Center Utrecht4 aut |
700 | 1 | a Volpe, Alessandrou University of Eastern Piedmont4 aut |
700 | 1 | a Staehler, Michaelu Ludwig-Maximilian University of Munich4 aut |
700 | 1 | a Ljungberg, Börje,d 1949-u Umeå University,Umeå universitet,Urologi och andrologi4 aut0 (Swepub:umu)bolj0001 |
700 | 1 | a Bex, Axelu Netherlands Cancer Institute4 aut |
710 | 2 | a Urologib Forskargrupper vid Lunds universitet4 org |
773 | 0 | t Scandinavian journal of urologyd : Taylor & Francis Groupg 53:1, s. 14-20q 53:1<14-20x 2168-1805x 2168-1813 |
856 | 4 | u https://www.repository.cam.ac.uk/bitstream/1810/290107/1/RECUR%20III%20imaging%20-%20Accepted%20copy.pdf |
856 | 4 | u http://dx.doi.org/10.1080/21681805.2019.1588919y FULLTEXT |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159078 |
856 | 4 8 | u https://doi.org/10.1080/21681805.2019.1588919 |
856 | 4 8 | u https://lup.lub.lu.se/record/5ee01ea4-4138-4b01-9013-c9dd7f4a499d |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.